[1]
Formigli L., Papucci L., Tani A. et al.: Aponecrosis: morphological and
biochemical exploration of a syncretic process of cell death sharing
apoptosis and necrosis. J Cell Physiol. 2000; 182: 41–49.
[2]
Artemowicz B., Sobaniec W.: Rola aminokwasów pobudzających w
padaczce i drgawkach. Epileptologia 1997; 5: 189–207.
[3]
Choi D.W.: Excitotoxic cell death. J Neurobiol 1992; 23: 1261–1276.
[4]
Bittigau P., Ikonomidou C.: Glutamate in neurologic diseases. J Child
Neurol 1997; 12: 471– 485.
[5]
Yakovlev A.G., Faden A.I.: Mechanism of neural cell death: implications
for development of neuroprotective strategies. Neuro Rx 2004; 1: 5–16.
[6]
Dougherty J.A., Rhoney D.H.: Gabapentin: a unique anti-epileptic agent.
Neurol Res 2001: 23: 821-829.
[7]
Tzellos T.G., Papazisis G., Toulis K.A. et al.: A2delta ligands gabapentin
and pregabalin: future implications in daily clinical practice. Hippokratia
2010; 14: 71-75.
[8]
Andrews C.O., Fischer J.H.: Gabapentin: a new agent for the
management of epilepsy. Ann Pharmacother 1994; 28: 1188–1196.
[9]
Sills G.J.: The mechanism of action of gabapentin and pregabalin. Curr
Opin Pharmacol 2006; 6: 108-113.
[10]
Gee N.S., Brown J.P., Dissanayake V.U. et al.: The novel anticonvulsant
drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a
calcium channel. J Biol Chem 1996; 271: 5768-5776.
[11]
Fink K., Dooley D.J., Meder W.P. et al. Inhibition of neuronal Ca(2+)
influx by gabapentin and pregabalin in the human neocortex.
Neuropharmacology 2002; 42: 229–236.
[12]
Sendrowski K., Sobaniec W.: New antiepileptic drugs — an overview.
Rocz Akad Med Bialymst 2005; 50(Suppl 1): 96–98.
[13]
Dooley D.J., Mieske C.A., Borosky S.A.: Inhibition of K+-evoked
glutamate release from rat neocortical and hippocampal slices by
gabapentin. Neurosci Lett 2000; 280:107–110.
[14]
Sarantopoulos C., McCallum B., Sapunar D. et al.: ATP-sensitive
potassium channels in rat primary afferent neurons: the effect of
neuropathic injury and gabapentin. Neurosci Lett 2003; 343: 185-189.
[15]
Sendrowski K., Sobaniec W., Iłendo E., Jałosińska I.: Primary culture
of dissociated hippocampal neurons – the use of method in the
experimental models of neuroprotection. Child Neurology 2008; 33:
49–54.
[16]
Meldrum B.S.: Glutamate as a neurotransmitter in the brain. Review of
Physiology and Pathology. J Nutrition 2000; 130: 1007–1015.
[17]
Sendrowski K., Boćkowski L., Sobaniec W. et al.: Levetiracetam
protects hippocampal neurons in culture against hypoxia-induced injury.
Folia Histochem Cytobiol 2011,1: 148-152.
[18]
Szydlowska K., Tymianski M.: Calcium, ischemia and excitotoxicity. Cell
Calcium 2010; 47: 122-129.
[19]
Stępień K., Tomaszewski M., Czuczwar S.J.: Profile of anticonvulsant
activity and neuroprotective effects of novel and potential antiepileptic
drugs — an update. Pharmacol Rep 2005; 57: 719–733.
[20]
Sendrowski K., Sobaniec W., Sobaniec-Lotowska M.E., Artemowicz B.:
Topiramate as a neuroprotectant in the experimental model of febrile
seizures. Adv Med Sci 2007; 52 (Suppl 1): 161-165.
[21]
Oka M., Itoh Y., Wada M. et al.: A comparison of Ca2+ channel blocking
mode between gabapentin and verapamil: implication for protection
against hypoxic injury in rat cerebrocortical slices. Br J Pharmacol 2003;
139: 435-443.
[22]
Sills G.J.: The mechanism of action of gabapentin and pregabalin. Curr
Opin Pharmacol 2006; 6: 108-113.
[23]
Comi A.M., Traa B.S., Mulholland J.B. et al.: Gabapentin neuroprotection
and seizure suppression in immature mouse brain ischemia. Pediatr Res
2008; 64: 81-85.
[24]
Baydas G., Sonkaya E., Tuzcu M. et al.: Novel role for gabapentin in
neuroprotection of central nervous system in streptozotocine-induced
diabetic rats. Acta Pharmacol Sin 2005; 26: 417-422.
[25]
KimY.S., Chang H.K., Lee J.W. et al.: Protective effect of gabapentin on
N-Methyl-D-aspartate–induced excitotoxicity in rat hippocampal CA1
neurons. J Pharmacol Sci 2009; 109, 144–147.
[26]
Dooley D.J., Mieske C.A., Borosky S.A.: Inhibition of K(+)-evoked
glutamate release from rat neocortical and hippocampal slices by
gabapentin. Neurosci Lett 2000; 280:107-110.
[27]
Stefani A., Spadoni F., Bernardi G.: Gabapentin reduces voltage-gated
calcium currents in central neurons. Neuropharmacology 1998; 37:
83–91.
[28]
Davies A., Hendrich J., Van Minh A.T. et al.: Functional biology of
the alpha(2)delta subunits of voltage-gated calcium channels. Trends
Pharmacol Sci 2007; 28: 220–228.
Scholar Google
PubMed